{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:37:10Z","timestamp":1767897430276,"version":"3.49.0"},"reference-count":13,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,2,1]]},"DOI":"10.2169\/internalmedicine.1922-23","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T22:14:24Z","timestamp":1685484864000},"page":"433-438","source":"Crossref","is-referenced-by-count":2,"title":["Low-density Lipoprotein Receptor Activities, Lipids, Apolipoprotein, and Clinical Course of Patients with Steroid-resistant Nephrotic Syndrome Treated with Low-density Lipoprotein Apheresis: A Case Series"],"prefix":"10.2169","volume":"63","author":[{"given":"Hisato","family":"Shima","sequence":"first","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Higashiguchi","sequence":"additional","affiliation":[{"name":"Department of Clinical Engineering, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Clinical Engineering, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Minakuchi","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 90: 41-52, 2016.","DOI":"10.1016\/j.kint.2016.02.026"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Muso E. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome. Clin Exp Nephrol 18: 286-290, 2014.","DOI":"10.1007\/s10157-013-0930-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shima H, Doi T, Okamoto T, et al. Successful treatment of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis accompanied by acute interstitial nephritis. Intern Med 61: 1863-1867, 2022.","DOI":"10.2169\/internalmedicine.8258-21"},{"key":"4","unstructured":"4. Muso E, Yashiro M, Matsushima M, Yoshida H, Sawanishi K, Sasayama S. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 9: 257-264, 1994."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ito H, Naito C, Hayashi H, Kawamura M. Activity of low-density lipoprotein receptors as estimated from concentrations of apolipoprotein B and C-II in serum. Clin Chem 34: 2224-2227, 1988.","DOI":"10.1093\/clinchem\/34.11.2224"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47, 1986.","DOI":"10.1126\/science.3513311"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Muso E, Mune M, Hirano T, et al. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study. Clin Exp Nephrol 19: 379-386, 2015.","DOI":"10.1007\/s10157-014-0996-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Sprecher DL, Hoeg JM, Schaefer EJ, et al. The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism 34: 294-299, 1985.","DOI":"10.1016\/0026-0495(85)90015-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kockx M, Glaros E, Leung B, et al. Low-density lipoprotein receptor-dependent and low-density lipoprotein receptor-independent mechanisms of cyclosporin a-induced dyslipidemia. Arterioscler Thromb Vasc Biol 36: 1338-1349, 2016.","DOI":"10.1161\/ATVBAHA.115.307030"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kaneva AM, Potolitsyna NN, Bojko ER, Odland JO. The apolipoprotein B\/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity. Dis Markers 2015: 591454, 2015.","DOI":"10.1155\/2015\/591454"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. McQueen MJ, Hawken S, Wang X, et al.; INTERHEART Study Investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 372: 224-233, 2008.","DOI":"10.1016\/S0140-6736(08)61076-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Raina R, Krishnappa V. An update on LDL apheresis for nephrotic syndrome. Pediatr Nephrol 34: 1655-1669, 2019.","DOI":"10.1007\/s00467-018-4061-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Baek HS. Mechanism, clinical consequences, and management of dyslipidemia in children with nephrotic syndrome. Childhood Kidney Dis 26: 25-30, 2022.","DOI":"10.3339\/ckd.22.020"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/3\/63_1922-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T03:33:28Z","timestamp":1706931208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/3\/63_1922-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1922-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"article-number":"1922-23"}}